Illustration of CGRP being released by nerve endings and being targeted by CGRP inhibitors which is emphasized with orange circles.

Migraine - Management


Targeting CGRP: A new approach to migraine care

Headache disorders, one of the most common being migraine, were the second most disabling impairments worldwide in 2017.1 As strides in migraine pathophysiology were made to address such a prevalent disease, new classes of migraine medication have been developed over the last three decades.Relevant to this progress is calcitonin gene related peptide (CGRP), a neuroi

Login to register to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

Log In

Not registered yet? Register now